PaxVax

About PaxVax PaxVax is a leading independent vaccine company that is devoted to bringing specialty vaccines that protect against overlooked infectious diseases to market, providing effective tools for health care providers who serve the 100 million people per year who travel to countries where these diseases are present. It commercializes vaccines for typhoid fever (Vivotif®) and cholera (Vaxchora®) and has a robust pipeline with vaccines at various stages of preclinical and clinical development for diseases including adenovirus and chikungunya. As part of its social mission, PaxVax is also committed to making its vaccines available for use in developing world and increasing access to vaccines for the people who need them most. PaxVax is majority owned by an affiliate of Cerberus Capital Management, L.P. a global leader in alternative investing.